Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Autor: Cornelius J. Clancy, Philipp Koehler, Jeroen Schouten, Stijn Blot, Roger J. M. Brüggemann, Elie Azoulay, Oliver A. Cornely, Paul E. Verweij, Matteo Bassetti, Peter Wei Lun Liu, Frank L. van de Veerdonk, Alejandro Rodriguez, Thomas R. Rogers, Olivier Lortholary, Ignacio Martin-Loeches, Cornelia Lass-Flörl, Pieter Depuydt, Russell E. Lewis, Joost Wauters, Katrien Lagrou, Jochem B. Buil, Thierry Calandra, Dylan W. de Lange, Thomas F. Patterson, Tom Chiller, Bart J. A. Rijnders, Johan Maertens, M. Hong Nguyen

Publikováno v: Intensive Care Medicine, 47, 819-834
Intensive care medicine, vol. 47, no. 8, pp. 819-834
INTENSIVE CARE MEDICINE
Intensive Care Medicine
Intensive Care Medicine, 47, 8, pp. 819-834
Intensive Care Medicine, 47(8), 819-834. Springer-Verlag

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU). Diagnosis and management of COVID-19 associated pulmonary aspergillosis (CA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdcf0b0b8622fe3d20292002e87a3f4
https://doi.org/10.1007/s00134-021-06449-4

Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions

Autor: Matthias Egger, Linda Bussini, Martin Hoenigl, Michele Bartoletti

Publikováno v: Journal of fungi (Basel, Switzerland), vol 8, iss 4

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis (CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely due to the fact that CAPA was, and still remains, challenging to diagnose in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfdb5180d806657c89ac2ee71e7ed880
http://hdl.handle.net/11585/884301

Choosing the Right Antifungal Agent in ICU Patients

Autor: Jeanne Chatelon, Marc Leone, Andrea Cortegiani, Nadim Cassir, Emmanuelle Hammad

Publikováno v: Advances in Therapy
Advances in Therapy, Springer Verlag (Germany), 2019, 36 (12), pp.3308-3320. ⟨10.1007/s12325-019-01115-0⟩
Advances in Therapy, 2019, 36 (12), pp.3308-3320. ⟨10.1007/s12325-019-01115-0⟩

Fungi are responsible for around 20% of microbiologically documented infections in intensive care units (ICU). In the last decade, the incidence of invasive fungal infections (IFI), including candidemia, has increased steadily because of increased nu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6feb19f172d4ebb0f9a596ae3d14627f
https://doi.org/10.1007/s12325-019-01115-0

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

Autor: Thomas R. Rogers, Cornelia Lass-Flörl, Stijn Blot, Joost Wauters, Nico A F Janssen, Bart Jan Kullberg, Russell E. Lewis, Pieter Depuydt, Bart J. A. Rijnders, Paul E. Verweij, Cornelius J. Clancy, Johan Maertens, Peter Wei Lun Liu, Roger J. M. Brüggemann, Matteo Bassetti, Jeroen Schouten, Daniele Roberto Giacobbe, Isabel Spriet, Thomas F. Patterson, Olivier Lortholary, Thierry Calandra, Frank L. van de Veerdonk, Katrien Lagrou, M. Hong Nguyen, Tom Chiller, Lore Vanderbeke, Elie Azoulay, Oliver A. Cornely, Ignacio Martin-Loeches

Publikováno v: Intensive Care Medicine
INTENSIVE CARE MEDICINE
Intensive Care Medicine, 46, 1524-1535
Intensive Care Medicine, 46, 8, pp. 1524-1535
Intensive Care Medicine, 46(8), 1524-1535. Springer-Verlag

PURPOSE: Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU). Classification of patients with influenza-associated pulmonary aspergillosis (IAPA) using the current definitions

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3ac1d0d62baf89c0105bc8f435a73c
https://hdl.handle.net/11585/800365

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies

Autor: Russell E. Lewis, Dimitrios P. Kontoyiannis, Michele Cavo, Nicola Vianelli, Marta Stanzani

Publikováno v: The Journal of infection. 78(6)

Objective Our objective was to develop a model that predicts a patient's risk of developing invasive mould disease (IMD) within 60 days of admission for treatment of a haematological malignancy. Methods We analysed 19 risk factors for IMD in a cohort

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dadfa144f73c4a3e20a0eadbb9f47c7
https://pubmed.ncbi.nlm.nih.gov/30974130